CNSP · Insider trading · 13F holders · Congress trades
CNS Pharmaceuticals, Inc. (CNSP)
Who is buying and selling CNSP: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $10K
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
CNSP at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 CNSP insider filed 1 open-market purchase worth $10K on SEC Form 4.
- No 13F filer reports CNSP among its 50 largest positions.
- No member of Congress has disclosed a trade in CNSP.
- CNSP last closed at $4.77 on Oct 29, 2026.
CNSP insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 CNSP insider filed 1 open-market purchase worth $10K on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Fisher Michal | Director | Buy | 2,000 | $5.00 | $10K | SEC |
Who owns CNSP? Hedge funds and superinvestors
No 13F filer reports CNSP among its 50 largest positions.
CNSP stock trades by members of Congress
No member of Congress has disclosed a trade in CNSP.
CNSP questions and answers
Are insiders buying CNSP stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 CNSP insider filed 1 open-market purchase worth $10K on SEC Form 4.
Which hedge funds own CNSP?
No 13F filer reports CNSP among its 50 largest positions.
Has Congress traded CNSP?
No member of Congress has disclosed a trade in CNSP.
Cite or share this
Free to use with a link back. The data updates every filing day.